Amphastar Pharmaceuticals (AMPH) Revenue (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) revenue from Jun 30, 2013 to Mar 31, 2026. The TTM Amphastar Pharmaceuticals (AMPH) revenue is $721M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Amphastar Pharmaceuticals (AMPH) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -1.39% |
| 3 Years TTM | +11.58% |
| 5 Years TTM | +14.37% |
| 10 Years TTM | +10.99% |
| All Time TTM | +14.02% |
Annual Revenue change of Amphastar Pharmaceuticals (AMPH)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $171M | -76.22% |
| 2025 | $720M | -1.65% |
| 2024 | $732M | +13.59% |
| 2023 | $644M | +29.14% |
| 2022 | $499M | +13.98% |
| 2021 | $438M | +25.13% |
| 2020 | $350M | +8.53% |
| 2019 | $322M | +9.40% |
| 2018 | $295M | +22.69% |
| 2017 | $240M | -5.87% |
| 2016 | $255M | +1.45% |
| 2015 | $252M | +19.51% |
| 2014 | $210M | -8.37% |
| 2013 | $230M | +12.41% |
| 2012 | $204M | N/A |
Comparison Amphastar Pharmaceuticals (AMPH) five years revenue CAGR with competitors
Amphastar Pharmaceuticals (AMPH) five years revenue CAGR is 14.37%.